| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 18, 2011Clinical Data from Multiple Studies Presented at EuroPCR Show Next-Generation Device Delivers Excellent Safety and Efficacy in Challenging Patient Population
PARIS, May 18, 2011 (BUSINESS WIRE) -- For patients with both heart disease and diabetes who took part in a pooled series of rigorous clinical trials, the Resolute drug-eluting stent (DES) from...
-
May 16, 2011Kyphon(R) Xpede(TM) Bone Cement Is the Latest Offering from Medtronic for Treatment of Spinal Fractures
MINNEAPOLIS, May 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced the U.S. launch of Kyphon Xpede Bone Cement, a quick-to-dough polymethylmethacrylate (PMMA) bone cement for...
-
May 13, 2011
MINNEAPOLIS, May 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year end 2011 on Tuesday, May 24, 2011....
-
May 9, 2011
MINNEAPOLIS & TARRYTOWN, N.Y., May 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) and Bayer HealthCare have expanded their international alliance to now include the United States and will...
-
May 5, 2011
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced findings from the DISCERN AF trial, which utilized Medtronic's Reveal(R) XT insertable...
-
May 5, 2011New Leads Add to Company's Expansive Portfolio of Innovative CRT-Related Technology Proven to Treat Heart Failure Patients
MINNEAPOLIS & SAN FRANCISCO, May 05, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the Attain Ability(R)...
-
May 3, 2011New Feature Set Includes External AC/DC Power and Temperature Monitoring for Therapeutic Hypothermia Patients
REDMOND, Wash., May 03, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc. (NYSE: MDT), today announced...
-
Apr 11, 2011Enlite(TM) SensorAvailable to Diabetes Patients for Continuous Glucose Monitoring in More Than 35 Countries
MINNEAPOLIS, Apr 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite(TM) Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring...
-
Apr 4, 2011Across Spectrum of Patients with Coronary Artery Disease, Novel Heart Device Shows Strong Results at One Year in RESOLUTE US and Two Years in RESOLUTE All Comers
NEW ORLEANS, Apr 04, 2011 (BUSINESS WIRE) -- Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology (ACC) -...
-
Apr 1, 2011Unique Sacral Nerve Stimulation Therapy Now Available for Treatment of Chronic Fecal Incontinence
MINNEAPOLIS, Apr 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of InterStim(R) Therapy for Bowel Control. InterStim...
-
Mar 9, 2011Facility established to meet the increase in demand for high quality cardiac devices in Asia
SINGAPORE, Mar 09, 2011 (BUSINESS WIRE) -- Medtronic, Inc., the global medical technology leader, announced today the official opening of its new manufacturing facility, Medtronic Singapore...
-
Mar 8, 2011CONNECT Trial Demonstrates Clinical and Economic Benefits of Remote Monitoring in Reducing Hospital Stays and In-Office Visits for Cardiac Patients Treated with Implantable Devices
MINNEAPOLIS, Mar 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced results from a clinical trial that showed remote monitoring of implantable cardiac device patients with the...
-
Mar 8, 2011Facility established to support further localization in the region
SHANGHAI, Mar 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc., the global medical technology leader, announced today the official opening of its new regional headquarters building in Shanghai, China....
-
Mar 3, 2011HeartRescue Project is first multi-state effort to systemically tackle one of nation's leading killers
MINNEAPOLIS, Mar 03, 2011 (BUSINESS WIRE) -- The Medtronic Foundation announced today a $15 million commitment to reduce sudden cardiac arrest deaths in the United States. The HeartRescue Project...
-
Mar 3, 2011"Global Heroes" Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October
MINNEAPOLIS, Mar 03, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the sixth...
-
Feb 20, 2011Revenue of $4.0 Billion Grew 3% on Strength of New Products
MINNEAPOLIS, Feb 22, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2011, which ended January 28, 2011. The company...
-
Feb 18, 2011CoreValve Italian Registry Results Demonstrate Clinical Benefits in a Real-World Patient Population
MINNEAPOLIS, Feb 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE:MDT) today issued a statement on results from an independent study published online in the journal Circulation, which confirmed...
-
Feb 17, 2011Advantages of Kyphon Balloon Kyphoplasty Include Better Back Pain Relief and Quality of Life, with Higher Patient Satisfaction, Study Shows
MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: TWO-YEAR STUDY CONTINUES TO...
-
Feb 17, 2011Advantages of Kyphon Balloon Kyphoplasty Include Better Back Pain Relief and Quality of Life, with Higher Patient Satisfaction, Study Shows
MINNEAPOLIS, Feb 17, 2011 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT), announced today thattwo-year data from the largest multicenter randomized controlled study of Kyphon Balloon Kyphoplasty...
-
Feb 16, 2011Study Showed Minimally Invasive Procedure Provided Better Back Function, More Rapid Back Pain Relief and Improved Quality of Life Compared with Non-surgical Care
MINNEAPOLIS, Feb 16, 2011 (BUSINESS WIRE) -- Medtronic Inc., (NYSE: MDT) today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with...
-
Feb 16, 2011
MINNEAPOLIS, Feb 16, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that the U.S. Food and Drug Administration (FDA) has classified the corrections being made to product...
-
Feb 14, 2011
MINNEAPOLIS, Feb 14, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2011 on Tuesday, February 22,...
-
Feb 9, 2011Companies to launch RhinoChill Intranasal Cooling System in Europe and jointly develop future potential solutions
REDMOND, Wash. & SAN DIEGO, Feb 09, 2011 (BUSINESS WIRE) -- Physio-Control, Inc., a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, Inc., (NYSE: MDT) and...
-
Feb 8, 2011Revo MRI(TM) SureScan(R) Pacing System Offers Pacemaker Patients Access to MRI Scans
MINNEAPOLIS, Feb 08, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved its Revo MRI(TM) SureScan(R) pacing system, the...
-
Jan 13, 2011Interventional Therapy Addresses Uncontrolled Hypertension with Renal Denervation
MINNEAPOLIS & MOUNTAIN VIEW, Calif., Jan 13, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), today announced that it has completed the acquisition of privately-held Ardian, Inc., a developer...